Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

References

• Gupta S, Hayek SS, Wang W, STOP-COVID Investigators, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1436.
   PubMed Web of Science ®Google Scholar
• Grasselli G, Greco M, Zanella A, COVID-19 Lombardy ICU Network, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345.
   PubMed Web of Science ®Google Scholar
• Galloway JB, Norton S, Barker RD, et al. A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study. J Infect. 2020.
   PubMed Web of Science ®Google Scholar
• de Lusignan S, Dorward J, Correa A, et al. Risk factors for SARS-CoV-2 among patients in the oxford royal college of general practitioners research and surveillance centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020;20(9):1034–1042.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Iwasaki A. Sex differences in immune responses. Science. 2021;371(6527):347–348.
   PubMed Web of Science ®Google Scholar
• Scully EP, Haverfield J, Ursin RL, et al. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20(7):442–447. Jul
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280 e8. Apr 16
   PubMed Web of Science ®Google Scholar
• Damodaran S, Lang JM, Jarrard DF. Targeting metastatic hormone sensitive prostate cancer: Chemohormonal therapy and new combinatorial approaches. J Urol. 2019;201(5):876–885.
   PubMed Web of Science ®Google Scholar
• Montopoli M, Zumerle S, Vettor R, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Ann Oncol. 2020;31(8):1040–1045.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. The National Library of Medicine (NLM) at the National Institutes of Health (NIH); 2020. [29 November 2020].
   Google Scholar
• Caffo O, Zagonel V, Baldessari C, et al. On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2. Ann Oncol. 2020;31(10):1415–1416.
   PubMed Web of Science ®Google Scholar
• Koskinen M, Carpen O, Honkanen V, et al. Androgen deprivation and SARS-CoV-2 in men with prostate cancer. Ann Oncol. 2020;31(10):1417–1418.
   PubMed Web of Science ®Google Scholar
• Gedeborg R, Styrke J, Loeb S, et al. Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic. PLoS One. 2021;16(10):e0255966.
   PubMed Web of Science ®Google Scholar
• Van Hemelrijck M, Garmo H, Wigertz A, et al. Cohort profile update: the national prostate cancer register of Sweden and prostate cancer data base-a refined prostate cancer trajectory. Int J Epidemiol. 2016;45(1):73–82.
   PubMed Web of Science ®Google Scholar
• Hagel E, Garmo H, Bill-Axelson A, et al. PCBaSe Sweden: a register-based resource for prostate cancer research. Scand J Urol Nephrol. 2009;43(5):342–349. 2009/01/01
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish cancer register: a sample survey for year 1998. Acta Oncol. 2009;48(1):27–33.
   PubMed Web of Science ®Google Scholar
• Brooke HL, Talback M, Hornblad J, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765–773.
   PubMed Web of Science ®Google Scholar
• Wallerstedt SM, Wettermark B, Hoffmann M. The first decade with the Swedish prescribed drug register - a systematic review of the output in the scientific literature. Basic Clin Pharmacol Toxicol. 2016;119(5):464–469.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
   PubMed Web of Science ®Google Scholar
• George G, Garmo H, Rudman S, et al. Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden. Scand J Urol. 2020;54(1):20–26.
   PubMed Web of Science ®Google Scholar
• Grundmark B, Garmo H, Zethelius B, et al. Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe Sweden. Eur J Clin Pharmacol. 2012;68(12):1619–1630.
   PubMed Web of Science ®Google Scholar
• Cindolo L, De Francesco P, Petragnani N, et al. Persistence and adherence to androgen deprivation therapy in men with prostate cancer: an administrative database study. Minerva Urol Nefrol. 2020;72(5):615–621.
   PubMed Web of Science ®Google Scholar
• Lycken M, Drevin L, Garmo H, et al. Adherence to guidelines for androgen deprivation therapy after radical prostatectomy: Swedish population-based study. Scand J Urol. 2020;54(3):208–214.
   PubMed Web of Science ®Google Scholar
• Suttmann H, Gleissner J, Huebner A, et al. Adherence measures for patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate plus prednisone: results of a prospective, cluster-randomized trial. Cancers (Basel). 2020;12(9):2550.
   Web of Science ®Google Scholar
• Paner GP, Stadler WM, Hansel DE, et al. Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol. 2018;73(4):560–569. Apr
   PubMed Web of Science ®Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. Nov
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Gedeborg R, Sund M, Lambe M, et al. An aggregated comorbidity measure based on the history of filled drug prescriptions – development and evaluation in two separate cohorts. Epidemiology. 2021;32(4):607–615.
   PubMed Web of Science ®Google Scholar
• Gedeborg R, Garmo H, Robinson D, et al. Prescription-based prediction of baseline mortality risk among older men. PLoS One. 2020;15(10):e0241439.
   PubMed Web of Science ®Google Scholar
• White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–399.
   PubMed Web of Science ®Google Scholar
• Savitz DA, Barón AE. Estimating and correcting for confounder misclassification. Am J Epidemiol. 1989; 129(5):1062–1071.
   PubMed Web of Science ®Google Scholar
• Patel VG, Zhong X, Liaw B, et al. Does androgen deprivation therapy protect against severe complications from COVID-19? Ann Oncol. 2020;31(10):1419–1420.
   PubMed Web of Science ®Google Scholar
• Caffo O, Gasparro D, Di Lorenzo G, et al. Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer. Eur J Cancer. 2020;140:140–146.
   PubMed Web of Science ®Google Scholar
• Klein EA, Li J, Milinovich A, et al. Androgen deprivation therapy in men with prostate cancer does not affect risk of infection with SARS-CoV-2. J Urol. 2021;205(2):441–443.
   PubMed Web of Science ®Google Scholar
• Meng Y, Lu W, Guo E, et al. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol. 2020;13(1):75.
   PubMed Web of Science ®Google Scholar
• Lee LYW, Cazier JB, Starkey T, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926.
   PubMed Web of Science ®Google Scholar
• Pranata R, Lim MA, Yonas E, et al. Body mass index and outcome in patients with COVID-19: a dose-response Meta-analysis. Diabetes Metab. 2021;47(2):101178.
   PubMed Web of Science ®Google Scholar
• Patanavanich R, Glantz SA. Smoking is associated with COVID-19 progression: a Meta-analysis. Nicotine Tob Res. 2020;22(9):1653–1656.
   PubMed Web of Science ®Google Scholar